These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 10355066)

  • 1. [Hypertrophic cardiomyopathy (HCM). Surgical versus drug therapy].
    Schulte HD; Gramsch-Zabel H; Schwartzkopff B; Gams E
    Z Kardiol; 1999 Mar; 88(3):163-72. PubMed ID: 10355066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H; Rigopoulos A
    Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of symptomatic hypertrophic obstructive cardiomyopathy--long-term results after surgical therapy.
    Schulte HD; Borisov K; Gams E; Gramsch-Zabel H; Lösse B; Schwartzkopff B
    Thorac Cardiovasc Surg; 1999 Aug; 47(4):213-8. PubMed ID: 10522789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertrophic obstructive cardiomyopathy: surgical treatment and results].
    Schulte HD; Lösse B
    Herz; 1985 Apr; 10(2):102-11. PubMed ID: 4039290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy.
    Kuhn H; Gietzen FH; Leuner C; Schäfers M; Schober O; Strunk-Müller C; Obergassel L; Freick M; Gockel B; Lieder F; Raute-Kreinsen U
    Z Kardiol; 2000; 89 Suppl 4():IV41-54. PubMed ID: 10810776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical pathology of subaortic septal myectomy: histology skips over clinical diagnosis.
    Abecasis J; Gouveia R; Castro M; Andrade MJ; Ribeiras R; Ramos S; Abecasis M; Cardim N; Gil V
    Cardiovasc Pathol; 2018; 33():32-38. PubMed ID: 29414430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Techniques and complications of transaortic subvalvular myectomy in patients with hypertrophic obstructive cardiomyopathy (HOCM).
    Schulte HD; Bircks W; Lösse B
    Z Kardiol; 1987; 76 Suppl 3():145-51. PubMed ID: 3433868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Septal myectomy results in regression of left ventricular hypertrophy in patients with hypertrophic obstructive cardiomyopathy.
    Deb SJ; Schaff HV; Dearani JA; Nishimura RA; Ommen SR
    Ann Thorac Surg; 2004 Dec; 78(6):2118-22. PubMed ID: 15561048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical aspects of typical subaortic and atypical midventricular hypertrophic obstructive cardiomyopathy (HOCM).
    Schulte HD; Bircks W; Körfer R; Kuhn H
    Thorac Cardiovasc Surg; 1981 Dec; 29(6):375-80. PubMed ID: 6179220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy of hypertrophic cardiomyopathy].
    Hartmann A; Kaltenbach M; Hopf R
    Fortschr Med; 1992 Sep; 110(27):485-8. PubMed ID: 1358773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interventional treatment in hypertrophic cardiomyopathy].
    Gietzen FH; Schümmelfeder J; Neuser H; Brunn J; Schumacher B; Kerber S
    Herz; 2005 Mar; 30(2):102-10. PubMed ID: 15875098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy.
    Samardhi H; Walters DL; Raffel C; Rateesh S; Harley C; Burstow D; Pohlner P; Aroney C
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):270-7. PubMed ID: 23873660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic approaches in symptomatic hypertrophic obstructive cardiomyopathy].
    Montijano Cabrera AM; Bouzas Zubeldía B; Penas Lado M; McKenna WJ
    Rev Esp Cardiol; 2001 Nov; 54(11):1311-26. PubMed ID: 11707242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment.
    Ball W; Ivanov J; Rakowski H; Wigle ED; Linghorne M; Ralph-Edwards A; Williams WG; Schwartz L; Guttman A; Woo A
    J Am Coll Cardiol; 2011 Nov; 58(22):2313-21. PubMed ID: 22093509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives.
    Ammirati E; Contri R; Coppini R; Cecchi F; Frigerio M; Olivotto I
    Eur J Heart Fail; 2016 Sep; 18(9):1106-18. PubMed ID: 27109894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in medical treatment of hypertrophic cardiomyopathy.
    Hamada M; Ikeda S; Shigematsu Y
    J Cardiol; 2014 Jul; 64(1):1-10. PubMed ID: 24735741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy].
    Gao YC; Li Y; Han ZH; Zhang XL; Zhao H; Jiang TY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):333-6. PubMed ID: 17711659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.
    Sherrid MV; Barac I; McKenna WJ; Elliott PM; Dickie S; Chojnowska L; Casey S; Maron BJ
    J Am Coll Cardiol; 2005 Apr; 45(8):1251-8. PubMed ID: 15837258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertrophic obstructive cardiomyopathy: surgical treatment].
    Schulte HD; Gramsch-Zabel H; Schwartzkopff B
    Schweiz Med Wochenschr; 1995 Oct; 125(41):1940-9. PubMed ID: 7481652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.